Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Press ReleaseJun | 25 | 2020
ICU patients on ventilators who had abnormally high factor V activity were at higher risk for blood clots, and when factor V was lower, the risk for death was increased.
Los pacientes hospitalizados con infecciones graves por el COVID-19 que tienen altos niveles del factor V (proteína de coagulación sanguínea) corren un riesgo elevado de sufrir lesiones graves por coágulos sanguíneos como la trombosis venosa profunda o la embolia pulmonar.
The new base editing platform may help researchers understand and correct genetic diseases by selective editing of single DNA 'letters' across nucleobase classes.
A study by investigators from the Massachusetts General Hospital Cancer Center has found that, contrary to common assumptions, the fact that a specific genetic mutation is frequently found in particular tumors may not signify that mutation drives cancer development and progression.
A new animal model developed by Massachusetts General Hospital investigators promises to be less expensive, easier to use and to improve personalized therapies for cancers and potentially other diseases.
A Massachusetts General Hospital research team reports that several of the recently developed CRISPR base editors, which create targeted changes in a single DNA base, can induce widespread off-target effects in RNA, extending beyond the targeted DNA.
